Form D · Other Health Care
Voyager Biomedical, Inc.
Houston, TX · CIK 0001829401
Offering snapshot reported Apr 4, 2025 · SEC filing
- Reported sold
- $5.8M Offering amount: $9.8M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 21, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 4, 2025 | Initial | $5,799,417 | No comparison | 18 | SEC filing |
| Oct 22, 2020 | Initial | $995,000 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-543000
Source: Form D, filed Apr 4, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nathan Borgfeld | Promoter |
| Alan Glowczwski | Director |
| Ashok Gowda | Director |
| Monica Klos | Executive |
| April Lovelady | Promoter |
| Marcus Penna | Director, Executive |
| Bruce Shook | Director |
| Peter Smith | Promoter |
| Robert Smith | Promoter |
| Linda Spain | Director, Executive |
| Trevor Uhl | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
114 Holmes Road
Houston, TX, 77045
Houston, TX, 77045